Evaluation of depression in patients with bone metastasis before and after radiotherapy

Bone is the third most common site of metastasis after lung and liver. Most of the bone metastasis come from either prostate or breast cancers. The incidence of developing bone metastasis in advanced diseases is quite high. Besides; depression is common in cancer patients with metastasis. Beck Depression Inventory is used in assessment of depression in patients. External beam radiation therapy is an effective technique in achieving pain control in patients with bone metastasis. One hundred patients were included in the study according to their primary diseases. Patients were divided into four groups and Beck depression test was performed twice to determine the depression levels of the patients before and after radiotherapy. Before radiotherapy patients were given Beck-0 and after radiotherapy they were given Beck-1 Results of Beck -0 and Beck -1, were statistically significant among any group itself and among all groups p

___

1. Chambers A, Naumov G, Varghese H. Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 2001; 10: 243- 255.

2. Coleman R. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001; 27: 165-176.

3. Selvaggi G, Scagliotti G. Management of bone metastases in cancer: a review. Clin Rev Oncol Hematol 2005; 56: 365-378.

4. Cecchini M, Wetterwald A, Pluijm G, Thalmann G. Molecular and biological mechanisms of bone metastasis: EAU Update Series 2005; 3: 214-226.

5. Janjan N. Radiation of bone metastases: conventional techniques and the role of systemic radiopharmaceuticals. Cancer 1997; 80: 1628- 1645.

6. Firvida JL, Vinolas N, Munoz M. A critical factor in cancer management: A prospective comparative study of 400 patients. Age Ageing 1999; 28: 103-105.

7. Yancik R, Wesley MN, Ries LA. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer 1998; 82: 2123- 2134.

8. Yancik R. Cancer burden in the aged: An epidemiologic and demographic overview. Cancer 1997; 80: 1273-1283.

9. Alacacioglu A, Yavuzsen T, Dirioz M, Yilmaz U. Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands. Med Oncol 2009; 26(4): 415-419.

10. Chochinov H. Depression in cancer patients:Lancet Oncol 2001; 2: 499-505.

11. Paula JM, Sonobe HM, Nicolussi AC, Zago MM, Sawada NO. Symptoms of depression in patients with cancer of the head and neck undergoing radiotherapy treatment: a prospective study. [Article in English, Portuguese, Spanish] Rev Lat Am Enfermagem 2012; 20: 362-368.

12. Goreinstein C, Andrade L. Validation of Portuguese version of Beck Depression Inventory and State-trait Anxiety Inventory in Brazilian subjects:Braz J Med Biol Res 1996; 29: 453-457.

13. Sawada N.O, Juliana Maria de Paula Helena Megumi Sonobe, Marcia Maria Fontão Zago, Giselle Patricia Guerrero, Adriana Cristina Nicolussi. Depression, fatigue, and health-related quality of life in head and neck cancer patients: a prospective pilot study: Support Care Cancer. Published online 2012; 012: 1390-1392.

14. Hisli N. Beck Depresyon Envanteri'nin geçerliliği üzerine bir çalışma: Psikoloji Dergisi 1988; 6: 118- 122.

15. Sobin LH, Gospodarowicz MK, Wittekind C. TMN classification of malignant tumours: 7th ed. London. Wiley Blackwell 2009.

16. Hung MS, Chen IC, Lee CP, et al. Incidence and risk factors of depression after diagnosis of lung cancer: A nationwide population-based study. Medicine (Baltimore) 2017; 96: e6864.

17. [No authors listed] Depression can shorten lung cancer survival rates. Nurs Stand 2016; 31: 17.

18. Walker J, Hansen CH, Martin P, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a crosssectional analysis of routinely collected clinical data. Lancet Psychiatry 2014; 1(5): 343-350.

19. Chen J, Li W, Cui L, et al. Chemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression. J Cancer 2015; 6: 1121-1129.

20. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients:A metaanalysis. Cancer 2009; 115: 5349-5361.

21. Katagiri H, Takahashi M, Wakai K, et al. Prognostic factors and a scoring system for patients with skeletal metastasis: J Bone Jt Surg Br 2005; 87: 1505-1512.

22. Mizumoto M, Harada H, Asakura H, et al Prognostic factors and a scoring system for survival after radiation therapy for metastases to spinal column: a review of 544 patients at Shizuoka Cancer Center Hospital. Cancer 2008; 113: 2816-2822.

23. Jehn C. F. Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer: Breast Cancer Res Treat 2012; 136: 789- 794.

24. O'Connor M, White K, Kristjanson LJ, Cousins K, Wilkes L. The prevalence of anxiety and depression in palliative care patients with cancer in Western Australia and New South Wales. Med J Aust 2010; 193: 44-47.
Eastern Journal of Medicine-Cover
  • ISSN: 1301-0883
  • Başlangıç: 1996
  • Yayıncı: ERBİL KARAMAN